Idexx Laboratories (IDXX) Consolidated Net Income (2009 - 2026)

Idexx Laboratories (IDXX) has reported Consolidated Net Income for 18 consecutive years, with $278.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Consolidated Net Income rose 14.74% year-over-year to $278.4 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 22.38% YoY), while the FY2025 annual figure was $1.1 billion, up 19.33% from the prior year.
• Consolidated Net Income came in at $278.4 million for Q1 2026 at Idexx Laboratories, up from $248.2 million in the prior quarter.
• The five-year high for Consolidated Net Income was $294.0 million in Q2 2025, with the low at $132.0 million in Q2 2022.
• Average Consolidated Net Income over 5 years is $220.6 million, with a median of $216.1 million recorded in 2024.
• Across the five-year window, Consolidated Net Income sank 34.86% in 2022 and soared 69.9% in 2023, its largest moves.
• Year by year, Consolidated Net Income stood at $172.2 million in 2022, then rose by 12.96% to $194.5 million in 2023, then advanced by 11.12% to $216.1 million in 2024, then rose by 14.82% to $248.2 million in 2025, then grew by 12.19% to $278.4 million in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered $278.4 million, $248.2 million, and $274.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.